Company intelligence / Profile preview

Rundo International Pharmaceutical Research & Development

Shanghai, Shanghai, Chinarundo-cro.com ↗

Ownership: Private
Development stage: Other

Overview

Rundo has completed more than 1,500 clinical trial projects ranging from Phase I to Phase IV in multiple therapeutic areas including oncology, cardiovascular, respiratory, digestive, endocrine, neurological and anti-infection. The company is recognized for high-quality clinical trial management and compliance with international standards such as ICH-GCP and NMPA regulations.

Therapeutic areas: OncologyPulmonologyEndocrinologyGastroenterologyCardiovascularNeurologyInfectious Diseases
Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Partnerships

Founding member of the China CRO Union

Beyond the preview

Go deeper on Rundo International Pharmaceutical Research & Development.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rundo International Pharmaceutical Research & Development.

Explore the full profile